Compounds > cefoperazone
Page last updated: 2024-08-23

cefoperazone and cilastatin

cefoperazone has been researched along with cilastatin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's5 (50.00)18.2507
2000's2 (20.00)29.6817
2010's1 (10.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Shevchuk, YM1
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R1
Kumagai, K; Nishibuchi, M; Otsuki, H; Takeda, Y1
Black, D; Kirby, WM; Kwok, K; Miller, S; Mortimer, J1
Nakagawa, Y; Toyoguchi, T1
Başkan, S; Ozyilkan, O; Yalçintaş, U1
Choi, JY; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Kim, YK; Lee, K; Park, YS; Shin, SY; Song, YG; Yong, D; Yoon, HJ1
Araya, I; Contreras, S; Fasce, G; Hurtado, V; Núñez, E; Opazo, JL; Quiñones, LA; Saez, E1
Dang, ZL; Li, B; Qin, HY; Rao, Z; Wei, YH; Wu, XA; Zhu, L1

Trials

2 trial(s) available for cefoperazone and cilastatin

ArticleYear
Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
    The American journal of medicine, 1988, Jul-25, Volume: 85, Issue:1A

    Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Mezlocillin; Neoplasms; Neutropenia; Thienamycins

1988
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
    The Korean journal of internal medicine, 1999, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam

1999

Other Studies

8 other study(ies) available for cefoperazone and cilastatin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Antimicrobial agents in neutropenic patients with unexplained fever.
    The Journal of infectious diseases, 1991, Volume: 163, Issue:1

    Topics: Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Fever of Unknown Origin; Humans; Imipenem; Infections; Neutropenia

1991
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
    The Japanese journal of antibiotics, 1991, Volume: 44, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin

1991
[An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
    The Japanese journal of antibiotics, 1990, Volume: 43, Issue:9

    Topics: Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens

1990
[Nephrotoxicity and drug interaction of vancomycin (2)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1996, Volume: 107, Issue:5

    Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin

1996
Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.
    Yonsei medical journal, 2006, Feb-28, Volume: 47, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefoperazone; Cilastatin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Protease Inhibitors; Sulbactam

2006
A Non-inferiority Pilot Study Comparing the Clinical Efficacy and Safety of Generic Wide-spectrum Antibiotic Use in Septic Oncology Patients.
    Drug research, 2015, Volume: 65, Issue:12

    Topics: Administration, Intravenous; Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drugs, Generic; Female; Humans; Imipenem; Male; Middle Aged; Oncology Service, Hospital; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sepsis; Sulbactam; Treatment Outcome

2015
Determination of Total and Unbound Meropenem, Imipenem/Cilastatin, and Cefoperazone/Sulbactam in Human Plasma: Application for Therapeutic Drug Monitoring in Critically Ill Patients.
    Therapeutic drug monitoring, 2020, Volume: 42, Issue:4

    Topics: Cefoperazone; Chromatography, High Pressure Liquid; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Drug Monitoring; Humans; Imipenem; Meropenem; Plasma; Sulbactam; Tandem Mass Spectrometry

2020